Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LUXEMBOURG, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company, announced that its Chief Scientific Officer, Dr Maxim Skulachev, will give a full...
-
Mitotech to Host Key Opinion Leader Webinar on Visomitin®: A Potential Treatment for Dry Eye Disease
Mitotech to be joined by John D. Sheppard, M.D., M.M.Sc. (Virginia Eye Consultants), Paul M. Karpecki, O.D., F.A.A.O. (Clinical Director of Advanced Ocular Surface Disease at Kentucky Eye Institute),...
-
LUXEMBOURG, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company in ophthalmology, announced that the U.S. Food and Drug Administration (FDA) has...